MCL1 and gastrointestinal stromal tumor: Our results therefore provide evidence supporting the rationale for therapeutic strategies targeting both OPN and Mcl-1 to interrupt associated anti-apoptotic signaling in drug-resistant GIST for prevention of tumor progression.